HAO — Haoxi Health Technology Cashflow Statement
0.000.00%
Last trade - 00:00- $1.36m
- -$7.96m
- $54.83m
Annual cashflow statement for Haoxi Health Technology, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.245 | 0.97 | 1.29 | 3.88 | -9.54 |
| Depreciation | |||||
| Non-Cash Items | — | — | — | -5.69 | 7.48 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.918 | -1.85 | -2.05 | -1.84 | -0.819 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.671 | -0.872 | -0.748 | -3.36 | -2.57 |
| Capital Expenditures | -0.009 | -0.045 | -0.055 | -2.08 | 0 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | -3.07 | -1.5 | -4.5 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.009 | -0.045 | -3.13 | -3.58 | -4.5 |
| Financing Cash Flow Items | 1.3 | -0.58 | 0 | 8.12 | 9.72 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.933 | 1.8 | 9.32 | 8.9 | 9.33 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.238 | 0.91 | 5.45 | 1.96 | 2.31 |